Jacob A. Orville - Mar 3, 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
General Manager, Screening
Signature
/s/ Jacob A. Orville by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Mar 3, 2023
Transactions value $
-$325,000
Form type
4
Date filed
3/7/2023, 03:07 PM
Previous filing
Mar 1, 2023
Next filing
May 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Sale -$325K -5K -30.45% $65.00 11.4K Mar 3, 2023 Direct F1, F2
holding EXAS Common Stock 546 Mar 3, 2023 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in November 2022.
F2 In addition to the shares of Common Stock reported on this Form 4, which total 11,969 shares, Mr. Orville also holds, in the aggregate, an additional 43,869 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.